Skip to content

ABCLABCELLERA BIOLOGICS INC

CUSIP 00288U106 · common stock

4 tracked investors held ABCELLERA BIOLOGICS INC (ABCL) at the end of Q3 2026, worth $496.1M in total. The largest holder was Julian Baker, with 2.3% of its portfolio. 3 investors opened new positions this quarter, including Adar1 Capital Management.

Holders · Q3 2026
4
New holders
3
Value held
$496.1M
Quarter-end price (est.)
$14.59

Investors holding ABCL · Q3 2026

InvestorWeightSharesValueChange
Julian Baker
Baker Bros. Advisors LP
2.29%33,012,139$481.6MADD0.0%
Adar1 Capital Management
ADAR1 Capital Management, LLC
0.51%822,163$12MNEW
George Soros
Soros Fund Management LLC
0.03%150,000$2.2MNEW
Joel Greenblatt
Gotham Asset Management, LLC
0.00%17,318$252.7KNEW

History

QuarterHoldersNewSold outValue heldQuarter-end price (est.)
Q3 2026430$496.1M$14.59
Q2 2026100$259.1M$7.85
Q1 2026101$105.7M$3.49
Q4 2025200$94.5M$3.42